Nektar Therapeutics - Common Stock — 분기별 재무 통계 (NASDAQ:NKTR) | MetaTrader

전체 차트 열기

Financials

개요 성명 통계

영업활동으로 인한 현금 -46.19 M-49.05 M-45.74 M-48.76 M-64.96 M-44.3 M -203.76 M 투자 활동으로 인한 현금 60.21 M43.69 M49.62 M-94.87 M372 K-350.79 M -395.68 M 재무활동으로 인한 현금 83 K7 000211 K141.68 M38.67 M529.55 M 710.11 M 잉여 현금 흐름 -46.19 M-49.05 M-45.74 M-48.76 M-64.96 M-44.3 M -203.76 M

뉴스

Why I'm Still Neutral On Nektar Therapeutics After Alopecia Areata Extension Data (NKTR)

Wall Street Lunch: BP Slips After Ousting Chairman Albert Manifold Over Governance Concern

5 Healthcare Stocks Set to Join the Russell 3000 - TipRanks.com

3 Best Healthcare Stocks to Buy in May 2026, According to Analysts - TipRanks.com

Nektar Q1 Earnings & Revenues Lag Estimates, Pipeline in Focus

Nektar Therapeutics (NKTR) Q1 2026 Earnings Call Transcript

Nektar Therapeutics: This Stock Went Up 10x In The Last Year And It's Still Cheap

Nektar (NKTR) Moves 18.3% Higher: Will This Strength Last?

넥타 테라퓨틱스, 월요일 주가 18% 급등한 이유는?

Nektar Therapeutics (NKTR) Discusses 52-Week Topline Results From REZOLVE-AA Phase 2b Extension in Severe Alopecia Areata - Slideshow (NASDAQ:NKTR) 2026-04-20

Nektar Therapeutics (NKTR) Discusses 52-Week Topline Results From REZOLVE-AA Phase 2b Extension in Severe Alopecia Areata Transcript

Nektar Therapeutics Adds To Its 129% Two-Month Run With Alopecia News